Pricing Log in Create free account

CNS Pharmaceuticals, Inc. (CNSP) vs XTL Biopharmaceuticals Ltd. (XTLB)

CNS Pharmaceuticals, Inc. and XTL Biopharmaceuticals Ltd. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and XTL Biopharmaceuticals Ltd. are of similar size ($8.1M and $7.9M). Across the 8 metrics below, XTL Biopharmaceuticals Ltd. leads on 5 and CNS Pharmaceuticals, Inc. on 3.

Valuation

Metric CNSP XTLB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.36 9.71
P/B 1.82 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1.27 9.21
Earnings yield (486.39%) (14.29%) (33.15%)
Free cash flow yield (40.54%) (139.25%) (25.50%)

Profitability

Metric CNSP XTLB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (106.62%) 0.00% (56.36%)
Return on assets (91.64%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNSP XTLB Biotechnology median
Revenue growth (TTM) — (12.71%) 6.02%
EPS growth (last fiscal year) 92.34% (159.17%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSP XTLB Biotechnology median
Debt to equity 0.00 (1.83) 0.00
Current ratio 5.86 0.70 4.72
Net debt to EBITDA 0.45 (0.11) 0.96

Dividend

Metric CNSP XTLB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNSP XTLB Biotechnology median
Market cap 7.88m 8.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack